Chronic hepatitis B: Recommendations for therapy based on the natural history of disease in Australian patients

Journal of Clinical Virology

Volumn 32, Issue 2, 2005, Pages 122-127

  Bell, S J ^a   Lau, A ^a   Thompson, A ^a   Watson, K J R ^a   Demediuk, B ^a   Shaw, G ^a   Chen, R Y ^a   Ayres, A ^b   Yuen, L ^b   Bartholomeusz, A ^b   Locarnini, S A ^b   Desmond, P V ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b Vic Infect Dis Ref Laboratory   (Australia)

Author keywords

Chronic hepatitis B; Ethnicity; Genotype; Hepatitis B e antigen; Natural history; Perinatal

Indexed keywords

LAMIVUDINE; MEMBRANE ANTIGEN; VIRUS DNA;

ADULT; AUSTRALIA; CHRONIC HEPATITIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE SEVERITY; ETHNOLOGY; FEMALE; FIBROSIS; GENOTYPE; HEPATITIS B; HUMAN; HUMAN TISSUE; INFECTION RISK; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NEWBORN DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SCREENING; VIROLOGY; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 19944427569     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.10.009     Document Type: Article

References (13)

1. A. Ayres, S. Locarnini, and A. Bartholomeusz 2004 HBV genotyping and analysis for unique mutations Methods Mol Med 95 2004 125 149
2. F. Bonino, F. Rosina, and M. Rizzetto Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe Gastroenterology 90 5 Pt 1 1986 1268 1273
3. W.G. Cooksley, T. Piratvisuth, and S-.D. Lee Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B J Viral Hepat 10 4 2003 298 305
4. S.J. Hadziyannis Treatment options for chronic hepatitis B not responding to interferon J Hepatol 38 6 2003 853 855
5. S.J. Hadziyannis, and D. Vassilopoulos Hepatitis B e antigen-negative chronic hepatitis B Hepatology 34 4 Pt 1 2001 617 624
6. S.J. Hadziyannis, N.C. Tassopoulos, T.T. Chang, E.J. Heathcote, G. Kitis, and M. Rizzetto Three year study of Adefovir Dipivoxil (ADV) demonstrates sustained efficacy in presume precore mutant Chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES) J Hepatol 40 Suppl. 1 2004 17 Abstract
7. D.A. Hendricks, B.J. Stowe, B.S. Hoo, J. Kolberg, B.D. Irvine, and P.D. Neuwald Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay Am J Clin Pathol 104 1995 537 546
8. W.M. Lee Hepatitis B virus infection N Engl J Med 337 24 1997 1733 1745
9. A.S. Lok Natural history and control of perinatally acquired hepatitis B virus infection Dig Dis 10 1 1992 46 52
10. A.S. Lok, C.L. Lai, and P.C. Wu Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection Gastroenterology 92 6 1987 1839 1843
11. P. Marcellin, G.K. Lau, and F. Bonino Pegulated Alfa-2A (40 kD) (Pegasys) monotherapy is more effective than lamivudine monotherapy in the treatment of HBeAg negative chronic hepatitis B: 72-week results from a phase 3, partially double blind study of Pegasys alone vs. Pegasys plus lamivudine vs. lamivudine J Hepatol 40 Suppl. 1 2004 34 Abstract
12. B.G. O'Sullivan, H.F. Gidding, M. Law, J.M. Kaldor, G.L. Gilbert, and G.J. Dore Estimates of chronic hepatitis B virus infection in Australia, 2000 ANZJPH 28 2004 212 216
13. G.V. Papatheodoridis, and S.J. Hadziyannis Review article: current management of chronic hepatitis B Aliment Pharmacol Ther 19 1 2004 25 37